Cox, I J, Puri, B K · Prostaglandins, leukotrienes, and essential fatty acids · 2004 · DOI
This study reviewed how a specialized brain imaging technique called magnetic resonance spectroscopy can be used to detect chemical changes in the brains of people with chronic fatigue syndrome and other neuropsychiatric conditions. The technique is non-invasive and allows doctors to measure things like energy production, brain cell function, and neurotransmitter activity without surgery. The authors summarized findings from previous research showing what these brain chemistry changes look like in ME/CFS patients.
This study is important because it highlights how advanced neuroimaging techniques can reveal objective biochemical abnormalities in ME/CFS brains, potentially supporting the biological basis of the disease. By demonstrating that MRS can detect measurable differences in brain energy metabolism and cellular function, it provides a framework for moving beyond purely symptom-based diagnosis toward biomarker-driven understanding. This mechanistic approach validates the legitimacy of ME/CFS as a neurobiological disorder.
This review does not prove that MRS findings are diagnostic for ME/CFS or that they cause the symptoms patients experience. It does not provide prevalence data on how common these spectroscopic abnormalities are in ME/CFS populations, nor does it establish whether these changes are disease-specific or occur in other conditions. As a narrative review without original research data, it cannot establish causal relationships between observed biochemical changes and clinical outcomes.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →